Karo Group publishes the 2023 Sustainability Report

Today, on 15 April 2024, Karo Group* is publishing its 2023 Sustainability Report on the company’s website, www.karohealthcare.com. For further information, please contact: Christoffer Lorenzen, CEO, +46 735 017 620,…

Financial Report 2022

Interim report H1 2022

January – June · Revenues amounted to MSEK 1 965.3 (1 460.9), corresponding to an increase of +35% for the period.· The organic growth1 during the period was +6%. The…

Karo Pharma publishes the 2021 annual report

Today, on 12 April 2022, Karo Pharma is publishing its annual report for 2021 on the company’s website, www.karohealthcare.com. For further information, please contact: Lisa Westerdahl, Head of Corporate Communication,…

Year-end report 2021

Q4, October – December · Revenues amounted to MSEK 762.0 (721.2), corresponding to an increase of +6% for the period.· The organic growth1 during the fourth quarter was +9%. The…

Karo Pharma Quarterly report Q3 2021

July – September Revenues amounted to MSEK 738.5 (679.1), corresponding to an increase of +9% for the period. The organic growth1 during the third quarter was +13%. The currency impact…

Interim report Q2 2021

April – June Revenues amounted to MSEK 747.9 (688.9), corresponding to an increase of +9% for the period. The organic growth1 during the second quarter was +8%. The currency impact…

Interim report Q1 2021

January – March Revenues amounted to MSEK 713.0 (793.6), corresponding to a decrease of -10% for the period. The organic growth* during the first quarter was -16%. The currency impact…

Karo Pharma publishes the 2020 annual report

Today, on 30 March 2021, Karo Pharma is publishing its annual report for 2020 on the company’s website, www.karohealthcare.com. For further information, please contact: Jon Johnsson, CFO, 073-507 88 61,…

Year-end report 2020

Q4, October – December Net sales amounted to MSEK 721.2 (649.3). This corresponds to an increase of 11% for the period. The organic growth* during the fourth quarter was +1%….